ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,314, issued on Aug. 5, was assigned to MEDICOVESTOR INC. (Wilmington, Del.).
"Proteins that bind folate receptor alpha including fully-human antibodies" was invented by Seah Lim (Wilmington, Del.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes proteins that specifically bind human folate receptor alpha (FRalpha) with high affinity. These proteins include a recombinant human anti-FRalpha IgG1 that is suitable for use as a therapeutic antibody to treat cancers that express FRalpha. Other FRalpha-binding proteins are also described including antibody fragments, antibody conjugates, and fusion proteins."
The patent was filed on ...